Literature DB >> 16194294

Sexual risk for hepatitis B virus infection among hepatitis C virus-negative heroin and cocaine users.

J D Rich1, B J Anderson, B Schwartzapfel, M D Stein.   

Abstract

Hepatitis C virus (HCV) and hepatitis B virus (HBV) are highly prevalent, often co-occurring infections among drug users. We examined HBV prevalence and risk behaviour patterns among a group of HCV-negative heroin and/or cocaine users in order to understand HBV risk and prevention opportunities among this unique group. Of 164 people enrolled, 44% had injected drugs. Overall, 24% of participants tested positive for exposure to HBV; drug injectors (28%) were only slightly and not significantly (P=0.287) more likely to test positive than those who had never injected drugs (21%). HBV exposure was significantly associated with multiple indicators of greater sex risk. HBV status was not associated with any demographic characteristic, but participants who reported longer duration of cocaine use were significantly less likely to test positive to exposure for HBV. It appears that HBV risk among HCV-negative drug users in this cohort is primarily due to sexual behaviour.

Entities:  

Mesh:

Year:  2005        PMID: 16194294      PMCID: PMC2870415          DOI: 10.1017/S0950268805005248

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  20 in total

1.  Risk correlates of prevalent HIV, hepatitis B virus, and hepatitis C virus infections among noninjecting heroin users.

Authors:  V Anna Gyarmathy; Alan Neaigus; Maureen Miller; Samuel R Friedman; Don C Des Jarlais
Journal:  J Acquir Immune Defic Syndr       Date:  2002-08-01       Impact factor: 3.731

2.  Drug use patterns and infection with sexually transmissible agents among young adults in a high-risk neighbourhood in New York City.

Authors:  Samuel R Friedman; Peter L Flom; Benny J Kottiri; Jonathan Zenilman; Richard Curtis; Alan Neaigus; Milagros Sandoval; Thomas Quinn; Don C Des Jarlais
Journal:  Addiction       Date:  2003-02       Impact factor: 6.526

3.  Association between heroin use, needle sharing and tattoos received in prison with hepatitis B and C positivity among street-recruited injecting drug users in New Mexico, USA.

Authors:  M C Samuel; P M Doherty; M Bulterys; S A Jenison
Journal:  Epidemiol Infect       Date:  2001-12       Impact factor: 2.451

4.  Effect of coexisting HIV-1 infection on the diagnosis and evaluation of hepatitis C virus.

Authors:  M Bonacini; H J Lin; F B Hollinger
Journal:  J Acquir Immune Defic Syndr       Date:  2001-04-01       Impact factor: 3.731

Review 5.  Epidemiology of hepatitis C.

Authors:  M J Alter
Journal:  Hepatology       Date:  1997-09       Impact factor: 17.425

6.  Prevalence of HIV and hepatitis B and self-reported injection risk behavior during detention among street-recruited injection drug users in Los Angeles County, 1994-1996.

Authors:  J López-Zetina; P Kerndt; W Ford; T Woerhle; M Weber
Journal:  Addiction       Date:  2001-04       Impact factor: 6.526

Review 7.  Epidemiology of hepatitis B virus infections among injecting drug users: seroprevalence, risk factors, and viral interactions.

Authors:  O S Levine; D Vlahov; K E Nelson
Journal:  Epidemiol Rev       Date:  1994       Impact factor: 6.222

8.  Methadone treatment and HIV and hepatitis B and C risk reduction among injectors in the Seattle area.

Authors:  H Thiede; H Hagan; C S Murrill
Journal:  J Urban Health       Date:  2000-09       Impact factor: 3.671

9.  Incidence and risk factors for acute hepatitis B in the United States, 1982-1998: implications for vaccination programs.

Authors:  Susan T Goldstein; Miriam J Alter; Ian T Williams; Linda A Moyer; Franklyn N Judson; Karen Mottram; Michael Fleenor; Patricia L Ryder; Harold S Margolis
Journal:  J Infect Dis       Date:  2002-02-28       Impact factor: 5.226

10.  Preparations for AIDS vaccine trials. An automated version of the Risk Assessment Battery (RAB): enhancing the assessment of risk behaviors.

Authors:  H A Navaline; E C Snider; C J Petro; D Tobin; D Metzger; A I Alterman; G E Woody
Journal:  AIDS Res Hum Retroviruses       Date:  1994       Impact factor: 2.205

View more
  8 in total

1.  Latent classes of heroin and cocaine users predict unique HIV/HCV risk factors.

Authors:  P T Harrell; B E Mancha; H Petras; R C Trenz; W W Latimer
Journal:  Drug Alcohol Depend       Date:  2011-10-24       Impact factor: 4.492

2.  Predictors of Hepatitis B screening and vaccination status of young psychoactive substance users in informal settlements in Kampala, Uganda.

Authors:  Tonny Ssekamatte; John Bosco Isunju; Joan Nankya Mutyoba; Moses Tetui; Richard K Mugambe; Aisha Nalugya; Winnifred K Kansiime; Chenai Kitchen; Wagaba Brenda; Patience Oputan; Justine Nnakate Bukenya; Esther Buregyeya; Simon P S Kibira
Journal:  PLoS One       Date:  2022-05-19       Impact factor: 3.752

3.  Number of sexual partners and associations with initiation and intensity of substance use.

Authors:  Patricia A Cavazos-Rehg; Melissa J Krauss; Edward L Spitznagel; Mario Schootman; Linda B Cottler; Laura Jean Bierut
Journal:  AIDS Behav       Date:  2011-05

4.  Hepatitis A Virus among Drug Users and the Role of Vaccination: A Review.

Authors:  Fabio Lugoboni; Benedetta Pajusco; Anna Albiero; Gianluca Quaglio
Journal:  Front Psychiatry       Date:  2012-01-12       Impact factor: 4.157

5.  Let It "B"? The role of Hepatitis B universal vaccination among italian problematic drug users.

Authors:  Fabio Lugoboni; Raimondo Maria Pavarin; Chiara Resentera; Daniele Gambini
Journal:  Int J Environ Res Public Health       Date:  2015-04-13       Impact factor: 3.390

6.  Human immunodeficiency virus infection predictors and genetic diversity of hepatitis B virus and hepatitis C virus co-infections among drug users in three major Kenyan cities.

Authors:  Micah Oyaro; John Wylie; Chien-Yu Chen; Raphael O Ondondo; Anna Kramvis
Journal:  South Afr J HIV Med       Date:  2018-03-27       Impact factor: 2.744

7.  Sero-prevalence of Hepatitis B virus surface antigen and associated factors among women of reproductive age in Bench Maji Zone, Southwest Ethiopia: Community based cross-sectional study.

Authors:  Alemayehu Sayih Belay; Sisay Shewasinad Yehualashet; Dejene Derseh Abateneh; Kindie Mitiku Kebede
Journal:  Afr Health Sci       Date:  2022-03       Impact factor: 1.108

Review 8.  Bloodborne viral hepatitis infections among drug users: the role of vaccination.

Authors:  Fabio Lugoboni; Gianluca Quaglio; Paolo Civitelli; Paolo Mezzelani
Journal:  Int J Environ Res Public Health       Date:  2009-01-22       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.